Category: Metabolic and Bariatric Surgery

Metabolic surgery leads to weight loss, improved comorbid conditions, lower incidence of cardiovascular events, cancer, and death, but also carries risks.

Metabolic/bariatric surgery is an effective and durable treatment for obesity, resulting in significant weight loss and improvements in comorbid conditions, including type 2 diabetes. It is associated with a lower incidence of cardiovascular events, cancer, and death. However, there is a risk of weight regain and an increased risk of developing substance and alcohol use […]

Higher Weight Loss and Postprandial Regurgitation in Banded Sleeve Gastrectomy

Five-year results from a three-year randomized controlled trial comparing banded and non-banded sleeve gastrectomy (SG) showed that banded sleeve gastrectomy (BSG) resulted in significantly higher excess weight loss (9%) and total weight loss (4.2%) compared to non-banded SG. Most patients experienced remission of type 2 diabetes, with no significant difference between the two groups. However, […]

Association Between COVID-19 Diagnosis and Postoperative Outcomes in Bariatric Surgery Patients

Patients with a postoperative diagnosis of COVID-19 after bariatric surgery had worse outcomes, including a higher risk of anastomotic/staple line leak, postoperative pneumonia, and 30-day reoperation. However, patients who had COVID-19 before surgery had similar outcomes to those without COVID-19. The study suggests that it is safe to perform bariatric surgery on patients recently recovered […]

SF-BARI Score as a Standard Tool for Metabolic Bariatric Surgery Outcomes

Researchers analyzed data from two randomized clinical trials to assess the feasibility of using the Swiss-Finnish Bariatric Metabolic Outcome Score (SF-BARI score) as a standardized tool for measuring outcomes in metabolic bariatric surgery (MBS). They found that the SF-BARI score, which includes measures of weight loss, comorbidities, complications, and quality of life, was correlated with […]

High Incidence of Pancreatic Exocrine Insufficiency After Non-Pancreatic Upper Gastrointestinal Surgery: Implications for Enzyme Replacement Therapy

Approximately 36% of patients who undergo non-pancreatic upper gastrointestinal surgeries develop pancreatic exocrine insufficiency (PEI), which can have detrimental effects on their health. The incidence of PEI was found to be 23% after bariatric metabolic surgery and 50.4% after oesophagogastric resection, with even higher rates after certain procedures. Diagnostic testing using fecal elastase 1 was […]

International Consensus Guides Obesity Management: IFSO Delphi Study

In a Delphi survey involving 43 global obesity experts, unanimous consensus (≥70% agreement) was achieved on 15 essential definitions and reporting standards in metabolic bariatric surgery (MBS). Notable agreement (95/121 statements) covered preferred surgical procedures like Roux-en-Y gastric bypass and sleeve gastrectomy. Moderate consensus existed for specific procedures, but none for intra-gastric balloons. Agreement extended […]

Functional Evaluation After Sleeve Gastrectomy: Nuclear Scintigraphy Outperforms Volumetric Analysis

In evaluating post-sleeve gastrectomy patients, this study compared nuclear scintigraphy gastric emptying with three-dimensional multi-detector computed tomography (3D-MDCT) gastric volumetry. Poor weight loss group exhibited delayed gastric emptying compared to optimal weight loss group. Gastric emptying time correlated with weight loss parameters, while gastric volume did not. Nuclear scintigraphy, especially with a threshold of 21.2 […]

Evolution of Primary Care Practitioners’ Views on Bariatric Surgery Over a Decade

Over 10 years, a survey involving 452 primary care practitioners in Scotland revealed increased awareness of local bariatric referral criteria, with more making referrals. Despite recognizing the impact of bariatric surgery on weight and related diseases, knowledge gaps persisted regarding national guidelines. Comfort levels in managing post-operative patients remained unchanged. Referral hesitancy was attributed to […]

Global Benchmarks for Robotic Bariatric Surgery

A comprehensive study across 17 centers on four continents, comparing robotic bariatric surgery with laparoscopic benchmarks, involved 9,097 patients. In expert centers, robotic Roux-en-Y gastric bypass demonstrated lower benchmark cut-offs for hospital stay, bleeding, and ulceration but had a longer operation duration. Robotic sleeve gastrectomy outperformed its laparoscopic counterpart in most outcomes. Overall, newly established […]

Complex Bariatric Surgery Sequencing: Double Conversions from Adjustable Gastric Band to Sleeve Gastrectomy and Then to Roux-en-Y Gastric Bypass

Examining 276 cases, researchers found that patients undergoing double conversions from adjustable gastric band (AGB) to sleeve gastrectomy (SG) and then to Roux-en-Y gastric bypass (RYGB) primarily did so due to gastroesophageal reflux disease (GERD) or inadequate weight loss/weight regain. Those converted for weight issues had higher baseline body mass index and sleep apnea prevalence, […]